A Study to Assess the Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP (Q63811721)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | A Study to Assess the Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP |
clinical trial |
Statements
TAPER (English)
0 references
A Phase II, Open-label, Prospective, Single-arm, Study to Assess Ability of Eltrombopag to Induce Sustained Remission in Subjects With ITP Who Are Refractory or Relapsed After First-line Steroids (English)
0 references
2 November 2018
0 references
13 May 2022
0 references
101
0 references
18 year
0 references